Keyphrases
Disease Severity
100%
Bronchiectasis
100%
Neutrophil Extracellular Traps
100%
Antibiotic Response
100%
Multi-cohort Studies
100%
Treatment Response
33%
Sputum
33%
Disease Treatment
25%
Azithromycin
25%
Dundee
16%
Inflammatory Diseases
16%
Proteomics
16%
Asthma
16%
Clinical Response
16%
Acute Exacerbation
16%
Neutrophilic Inflammation
16%
Macrolides
16%
Intravenous Antibiotic Treatment
16%
Bronchiectasis Severity Index
16%
Spain
8%
Italy
8%
Quality of Life
8%
Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS)
8%
Host Defense
8%
Associated Proteins
8%
Severe Disease
8%
Hospital Admission
8%
Future Risk
8%
Pseudomonas Aeruginosa Infection
8%
Intravenous Antibiotics
8%
Novel Therapies
8%
Pathogenic Bacteria
8%
Immunoassay
8%
Hospital Mortality
8%
Proteomic Response
8%
Markers of Disease Severity
8%
Pseudomonas Infections
8%
Observational Cohort
8%
Macrolide Therapy
8%
Trap Concentration
8%
Proteomic Biomarkers
8%
Medicine and Dentistry
Disease Severity
100%
Neutrophil
100%
Bronchiectasis
100%
Extracellular Trap
100%
Treatment Response
28%
Proteomics
28%
Sputum
28%
Combination Therapy
21%
Macrolide
21%
Azithromycin
21%
Inflammatory Disorder
14%
Pseudomonas Infection
14%
Biological Marker
14%
Antibiotic Therapy
14%
Observational Study
7%
Low Drug Dose
7%
Disease
7%
Asthma
7%
Cohort Analysis
7%
Antibiotics
7%
Quality of Life
7%
Patient with Asthma
7%
Immunoassay
7%
Post-Hoc Analysis
7%
Liquid Chromatography-Mass Spectrometry
7%
Host Resistance
7%
Immunology and Microbiology
Sputum
100%
Neutrophil Extracellular Traps
100%
Inflammatory Disorder
50%
Asthma
50%
Host Resistance
25%
Immunoassay
25%
Liquid Chromatography Tandem Mass Spectrometry
25%
Low Drug Dose
25%
Pseudomonas aeruginosa
25%
Pseudomonas
25%